高剂量放疗后中心气道毒性:非小细胞肺癌前瞻性临床试验汇总分析
该研究汇总接受常规分割三维适形放疗的非小细胞肺癌患者,按RTOG 1106图谱勾画近端支气管树(PBT),分析剂量学风险因素。结果显示PBT的V75是预测1级及以上和2级及以上PBT毒性的最显著剂量学参数,相应阈值分别为6.8%和11.9%。
要点
- PBT最大物理剂量<65 Gy者未发生任何PBT毒性。
- V75阈值:1级及以上为6.8%,2级及以上为11.9%。
核心结论
- PBT的V75似乎是常规分割胸部3DCRT后PBT毒性最显著的剂量学参数。
- 限制PBT的V75可限制临床显著的PBT毒性。
研究设计与样本
- 研究纳入在前瞻性临床试验中接受常规分割三维适形放疗的医学上无法手术或不可切除的非小细胞肺癌患者。
- PBT和PBT壁按RTOG 1106 OAR-Atlas一致勾画,分别生成物理处方剂量和生物有效剂量(α/β=2.5)的剂量体积直方图。
- 主要终点为CTCAE 4.0定义的支气管狭窄/肺不张术语下的PBT毒性。
- 共入组100例患者,中位随访64个月(95%CI 50-78)。
主要发现
- 73%的患者接受70 Gy或以上剂量。
- 17%的患者发生PBT毒性:1级8%、2级6%、3级0%、4级3%。
- 放疗开始至PBT毒性发生的中位时间间隔为8.4个月(95%CI 4.7-44.1)。
- PBT最大物理剂量<65 Gy的患者未发生任何PBT毒性。
关键数值与推荐
- PBT的V75阈值:1级及以上PBT毒性为6.8%,2级及以上PBT毒性为11.9%。
临床怎么用
- 在常规分割胸部3DCRT计划中,可将PBT的V75作为限制临床显著PBT毒性的剂量学参数。
局限性
- 原文未报告
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To study the dosimetric risk factors for radiation-induced proximal bronchial tree (PBT) toxicity in patients treated with radiation therapy for non-small cell lung cancer (NSCLC). METHODS AND MATERIALS: Patients with medically inoperable or unresectable NSCLC treated with conventionally fractionated 3-dimensional conformal radiation therapy (3DCRT) in prospective clinical trials were eligible for this study. Proximal bronchial tree (PBT) and PBT wall were contoured consistently per RTOG 1106 OAR-Atlas. The dose-volume histograms (DVHs) of physical prescription dose (DVHp) and biological effective dose (α/β = 2.5; DVH2.5) were generated, respectively. The primary endpoint was PBT toxicities, defined by CTCAE 4.0 under the terminology of bronchial stricture/atelectasis. RESULTS: Of 100 patients enrolled, with a median follow-up of 64 months (95% confidence interval [CI], 50-78), 73% received 70 Gy or greater and 17% developed PBT toxicity (grade 1, 8%; grade 2, 6%; grade 3, 0%; and grade 4, 3%). The median time interval between RT initiation and onset of PBT toxicity was 8.4 months (95% CI, 4.7-44.1). The combined DVHs showed that no patient with a PBT maximum physical dose <65 Gy developed any PBT toxicity. Cox proportional hazards analysis and receiver operating characteristic analysis demonstrated that V75 of PBT was the most significant dosimetric parameter for both grade 1+ (P = .035) and grade 2+ (P = .037) PBT toxicities. The dosimetric thresholds for V75 of PBT were 6.8% and 11.9% for grade 1+ and grade 2+ PBT toxicity, respectively. CONCLUSIONS: V75 of PBT appeared be the most significant dosimetric parameter for PBT toxicity after conventionally fractionated thoracic 3DCRT. Constraining V75 of PBT can limit clinically significant PBT toxicity.
引用
- Wang W, Matuszak MM, Hu C, et al. Central Airway Toxicity After High Dose Radiation: A Combined Analysis of Prospective Clinical Trials for Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2020. PMID: 32470501. doi:10.1016/j.ijrobp.2020.05.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。